Dataset Information

Integrated proteomic and multi-mic characterizations of the synapse reveal RNA processing factor and ubiquitin ligases associated with neurodevelopment disorders

ABSTRACT: The molecular composition of the excitatory synapse is incompletely defined due to its dynamic nature across developmental stages and neuronal populations. To address this gap, we apply proteomic mass spectrometry to characterize the synapse in multiple biological models including the fetal human brain and hiPSC-derived neurons. To prioritize the identified proteins, we develop an orthogonal multi-omic screen of genomic, transcriptomic, interactomic, and structural data. This data-driven framework identifies proteins with key molecular features intrinsic to the synapse, including characteristic patterns of biophysical interactions and cross-tissue expression. The integrated proteomic and multi-omic analysis captures synaptic proteins across developmental stages and experimental systems, including 492 proteins that have not been documented previously. We further investigate three such proteins that are associated with neurodevelopmental disorders – the CUL3 E3 ubiquitin ligase, the DDX3X and YBX1 nucleic-acid binding factors – by mapping their networks of physically interacting synapse proteins or transcripts. Our study demonstrates the potential of an integrated multi-omic approach to systematically and more comprehensively resolve the synaptic architecture.

ORGANISM(S): Homo sapiens

PROVIDER: GSE228444 | GEO | 2025/03/28

REPOSITORIES: GEO

ACCESS DATA

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Project description:As synapse degeneration is an early event in Alzheimer’s disease (AD) pathophysiology, a biofluid marker of synapse loss in living patients could be a surrogate marker of disease prognosis and therefore would be an excellent addition to the AD biomarker arsenal. With direct access to the brain interstitial fluid, the cerebrospinal fluid (CSF) is a potential source of synapse-derived proteins that could be potential biomarkers of underlying synapse degeneration. The aim of this study was to identify, verify and evaluate a set of synaptic proteins as surrogate CSF markers of underlying synapse loss in AD patients. In the Discovery Stage, we combined high-throughput shotgun proteomics of the CSF with an exhaustive search of the literature and public databases for proteomic studies of the CSF and synapse. A thorough characterization of the synaptic component of the CSF identified 210 synaptic proteins that are detectable in human CSF. We selected an initial panel of 22 candidate biomarkers for evaluation. In the Verification Stage, 12 proteins were discarded due to poor detection by targeted mass spectrometry (Selected Reaction Monitoring, SRM). We confirmed the expression of the remaining 10 proteins either directly at (Calsynytenin-1, GluR2, GluR4, Neurexins 2A and 3A, Neuroligin-2, Syntaxin-1B, Thy-1 and Vamp-2), or surrounding (Tenascin-R), the human synapse using Array Tomography microscopy and biochemical fractionation methods. We quantified the synaptic panel by SRM in CSF samples from 2 independent clinical cohorts of cognitively normal controls and all clinical stages of AD (n=140). A set of the panel proteins demonstrated a non-linear profile distinct to that of existing biomarkers whereby the CSF levels were decreased at the earliest preclinical stage of AD, reflecting reduced synaptic density in these asymptomatic individuals and elevated at later symptomatic stages when neurodegeneration is widespread. In conclusion, we have identified a set of novel synapse-specific proteins that could have clinical value for assessing disease progression in individuals at-risk for AD and potentially in other neurological disorders characterized by early synapse loss.

Project description:Alcoholism is a complex neurological disorder characterized by loss of control in limiting intake, and progressive compulsion to seek and consume ethanol. Prior studies have suggested that the characteristic behaviors associated with escalation of drug use are caused, at least in part, by ethanol-evoked changes in gene expression affecting synaptic plasticity. Implicit in this hypothesis is a dependence on new protein synthesis and remodeling at the synapse. It is well established that mRNA can be transported to neuronal distal processes, where it can undergo localized translation that is regulated in a spatially restricted manner in response to stimulation. It is unknown whether such modulation of the synaptic transcriptome might contribute to ethanol-induced synaptic plasticity. Using ethanol-induced behavioral sensitization as a model of neuroplasticity, here we investigated whether repeated exposure to ethanol altered the synaptic transcriptome, contributing to synaptic plasticity underlying a subsequent increase in the ethanol-evoked locomotor response. A synaptoneurosome preparation was utilized to enrich for RNAs trafficked to the synapse versus the proximal cellular fraction. Two complementary methods of genomic profiling, RNA-Seq and microarrays, were used to survey the synaptic transcriptome of DBA/2J mice subjected to ethanol-induced behavioral sensitization. Strikingly, a large number of genes regulated by acute ethanol showed adaptation to repeated ethanol exposure with sensitization. Genomic profiling showed distinct functional classes in RNA found to be enriched in the synaptoneurosome faction, consistent with their role in synaptic function. A subset of ethanol-responsive genes significantly enriched at the synapse were related to biological functions such as protein folding and extra-cellular matrix components, suggesting a role for local regulation of synaptic protein function by ethanol. In contrast, RNA classes regulated by ethanol in the cell soma included an over-abundance of RNA-binding and trafficking proteins, perhaps reflecting increased demand for dendritic RNA localization. These experiments document that both acute and repeated ethanol produce specific alterations in the complement of RNA at the synapse and lay the foundation for further investigations into the role of the synaptic transcriptome in behavioral adaptations to ethanol. 24 samples were analyzed from 3 treatment groups and 2 cell fractions with 4 biological replicates for each treatment/cell fraction.Cell fractionation was carried out on tissue from a frontal pole dissection of DBA2/J mice, isolating a cytosolic (S2) and synaptoneurosomal (P2) fraction. Treatment groups describe chronic treatment (10 daily injections) and treatment used on test day (single injeciion), producing saline-saline (SS), saline-ethanol (SE) and ethanol-ethanol (EE) groups. Analysis of RNA-seq compared similar treatments across cell fractions or different treatments within a cell fraction.

Dataset Information

Integrated proteomic and multi-mic characterizations of the synapse reveal RNA processing factor and ubiquitin ligases associated with neurodevelopment disorders

Dataset's files

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets